Wolfgang Hartwig
Algemeen Directeur bij Pharma R&D Consulting GmbH
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Bruno Montanari | M | 49 |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Ken Cunningham Cunningham | M | 71 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Keith McCullagh | M | 80 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Jonathan Charles Gee | M | 71 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Hugo Slootweg | M | 53 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Jörn Kreke | M | 84 |
URBANA Energiedienste GmbH
 URBANA Energiedienste GmbH Electric UtilitiesUtilities URBANA Energiedienste GmbH operates as an energy service provider. The firm's services include efficiency deals, energy plans, EcoQuartier management, current gantries and performance processes. The company was founded in 1963 and is headquartered in Hamburg, Germany. | - |
| Alan William O'Connell | M | - |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | - |
| Thomas Casdagli | M | 47 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | 8 jaar |
| Götz-Michael Müller | M | 76 |
University of Münster
| - |
| Klaus Backhaus | M | - |
University of Münster
| - |
| Petra Pohlmann | M | 63 |
University of Münster
| - |
| Florian Unger | M | - |
URBANA Energiedienste GmbH
URBANA Energiedienste GmbH Electric UtilitiesUtilities URBANA Energiedienste GmbH operates as an energy service provider. The firm's services include efficiency deals, energy plans, EcoQuartier management, current gantries and performance processes. The company was founded in 1963 and is headquartered in Hamburg, Germany. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Anja Krusel | F | - | 3 jaar | |
| Peter Seifried | M | 75 | 4 jaar | |
| Michael Hoffmann-Becking | M | 81 |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | - |
| Hans-Rainer Hoffmanns | M | - |
LTS LOHMANN Therapie-Systeme AG
LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | - |
| Luis Rauch | M | - | 1 jaar | |
| Thierry Chevrier | M | 55 | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Duitsland | 11 | 61.11% |
| Verenigd Koninkrijk | 7 | 38.89% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Wolfgang Hartwig
- Persoonlijk netwerk
